Frequency of CHEK2*1100delC in New York breast cancer cases and controls

BACKGROUND: The 1100delC CHEK2 allele has been associated with a 1.4–4.7 fold increased risk for breast cancer in women carrying this mutation. While the frequency of 1100delC was 1.1–1.4% in healthy Finnish controls, the frequency of this allele in a North American control population and in North A...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	BMC Med Genet
Ngā kaituhi matua:	Offit, Kenneth, Pierce, Heather, Kirchhoff, Tomas, Kolachana, Prema, Rapaport, Beth, Gregersen, Peter, Johnson, Steven, Yossepowitch, Orit, Huang, Helen, Satagopan, Jaya, Robson, Mark, Scheuer, Lauren, Nafa, Khedoudja, Ellis, Nathan
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2003
Ngā marau:	Research Article
Urunga tuihono:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149355/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12529183/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2350-4-1
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

Ngā tūemi rite